Table 2.
Age- and gender-standardized prevalence of CVD risk factors in Xinjiang by ethnic groups
| Ethnic groups (n) | Hypertension (%) | Diabetes (%) | Obesity (%) | Dyslipidemia (%) | Smoking (%) |
|---|---|---|---|---|---|
| Total |
|
|
|
|
|
| Overall(11608) |
44.2 |
5.5 |
15.6 |
51.7 |
28.6 |
| 35-44y(3999) |
28.1 |
3.1 |
12.7 |
48.0 |
30.6 |
| 45-54y(3339) |
43.8 |
3.2 |
17.3 |
52.9 |
29.7 |
| 55-64y(2559) |
56.2 |
6.6 |
18.6 |
54.4 |
26.1 |
| 65-74y(1711) |
65.0 |
8.4 |
14.7 |
53.5 |
25.6 |
| Men(5271) |
46.5 |
6.6 |
15.3 |
54.5 |
56.3 |
| Women(6337) |
42.3 |
4.6 |
15.9 |
49.3 |
5.6 |
| Han |
|
|
|
|
|
| Overall(3717) |
36.0 |
7.1 |
8.1 |
53.3 |
19.3 |
| 35-44y(1158) |
19.1 |
3.8 |
5.8 |
49.3 |
18.1 |
| 45-54y(1109) |
37.5 |
8.4 |
6.5 |
53.1 |
20.1 |
| 55-64y(952) |
46.0 |
8.1 |
11.7 |
58.4 |
20.1 |
| 65-74y(498) |
52.6 |
10.4 |
10.4 |
53.6 |
19.1 |
| Men(1583) |
35.1 |
8.4 |
8.9 |
54.4 |
45.4 |
| Women(2179) |
36.6 |
6.0 |
7.3 |
52.6 |
1.0 |
| Uygur |
|
|
|
|
|
| Overall(4695) |
43.7 |
5.4 |
17.6 |
54.3 |
31.1 |
| 35-44y(1643) |
29.2 |
2.8 |
16.2 |
51.6 |
32.9 |
| 45-54y(1228) |
37.7 |
5.5 |
20.0 |
57.1 |
35.2 |
| 55-64y(948) |
55.8 |
7.6 |
17.5 |
54.5 |
26.5 |
| 65-74y(876) |
66.1 |
7.2 |
15.3 |
55.1 |
26.9 |
| Men(2202) |
46.5 |
6.0 |
14.8 |
58.8 |
63.6 |
| Women(2493) |
41.2 |
5.0 |
19.6 |
50.3 |
2.4 |
| Kazakh |
|
|
|
|
|
| Overall(3196) |
54.6 |
3.4 |
24.5 |
45.9 |
35.8 |
| 35-44y(1198) |
35.1 |
2.5 |
18.8 |
42.0 |
39.6 |
| 45-54y(1002) |
58.2 |
4.2 |
27.3 |
47.6 |
33.7 |
| 55-64y(659) |
71.3 |
3.2 |
30.2 |
48.6 |
34.1 |
| 65-74y(337) |
80.7 |
5.0 |
24.9 |
49.3 |
31.8 |
| Men(1531) |
58.1 |
4.8 |
25.1 |
48.3 |
56.6 |
| Women(1665) | 51.4 | 2.2 | 23.8 | 43.6 | 16.6 |
Hypertension was defined as SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg and/or current antihypertensive drug use. Diabetes was defined as fasting plasma glucose ≥ 6.99 mmol/L and/or current diabetes drug use. Obesity was defined as BMI ≥ 30 kg/m2. Dyslipidemia was defined as TG ≥ 2.26 mmol/L, TC ≥ 6.22 mmol/L, HDL-C < 1.04 mmol/L, LDL-C ≥ 4.14 mmol/L, and/or current lipid-lowering drug use.